{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T22:56:07Z","timestamp":1752101767939},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.transproceed.2008.09.062","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T09:51:48Z","timestamp":1236160308000},"page":"167-169","source":"Crossref","is-referenced-by-count":1,"title":["Chlamydia Pneumoniae Infection in Patients After Kidney Transplantation Treated With Spiramycin"],"prefix":"10.1016","volume":"41","author":[{"given":"S.","family":"Fesolowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wszola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Podsiadly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Durlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Paczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tylewska-Wierzbanowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Rowinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chmura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2008.09.062_bib1","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2008.09.062_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0041-1345(03)00789-9","article-title":"Extracellular matrix proteins, proteolytic enzymes, and TGF-beta1 in the renal arterial wall of chronically rejected renal allografts","volume":"35","author":"Zegarska","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.09.062_bib3","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/j.1600-6143.2006.01559.x","article-title":"Risk factors for early epithelial to mesenchymal transition in renal grafts","volume":"6","author":"Hertig","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2008.09.062_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1432-2277.2006.00364.x","article-title":"Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival","volume":"19","author":"Helanter\u00e4","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2008.09.062_bib5","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0041-1345(01)02047-4","article-title":"CMV infection as a contributory factor for renal allograft injury and loss","volume":"33","author":"Gerstenkorn","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.09.062_bib6","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/01.TP.0000122184.97674.20","article-title":"Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated with decreased renal allograft and patient survival","volume":"77","author":"Fitzgerald","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.09.062_bib7","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.transproceed.2006.10.167","article-title":"The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells","volume":"38","author":"Daniel","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.09.062_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10096-005-1380-0","article-title":"Presence of Chlamydia pneumoniae in patients with and without atherosclerosis","volume":"24","author":"Podsiadly","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.transproceed.2008.09.062_bib9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(88)90741-6","article-title":"Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction","volume":"2","author":"Saikku","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2008.09.062_bib10","first-page":"337","article-title":"Azithromycin reduces cardiovascular events in post myocardial infection patients with elevated Chlamydia pneumoniae antibody titres","volume":"18","author":"Gupta","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.transproceed.2008.09.062_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/314931","article-title":"Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae","volume":"180","author":"Kalayoglu","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transproceed.2008.09.062_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/514241","article-title":"Induction of macrophage foam cell formation by Chlamydia pneumoniae","volume":"177","author":"Kalayoglu","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transproceed.2008.09.062_bib13","doi-asserted-by":"crossref","first-page":"S483","DOI":"10.1086\/315619","article-title":"Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions","volume":"181","author":"Kalayoglu","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transproceed.2008.09.062_bib14","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1128\/IAI.66.11.5067-5072.1998","article-title":"A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide","volume":"66","author":"Kalayoglu","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.transproceed.2008.09.062_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00007890-200203150-00018","article-title":"Correlation of Chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation","volume":"73","author":"Subramanian","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.09.062_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.transproceed.2005.12.033","article-title":"Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients","volume":"38","author":"Wszola","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.09.062_bib17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/01.CIR.0000012544.07696.1F","article-title":"Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome","volume":"105","author":"Sinisalo","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2008.09.062_bib18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa043526","article-title":"Azithromycin for the secondary prevention of coronary events","volume":"352","author":"Grayston","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2008.09.062_bib19","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/01.CIR.99.12.1540","volume":"99","author":"Anderson","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2008.09.062_bib20","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/jama.290.11.1459","article-title":"Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial","volume":"290","author":"O'Connor","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2008.09.062_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/003655102321004512","article-title":"Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in dialysis patients, renal transplant recipients and healthy controls","volume":"62","author":"Muller","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.transproceed.2008.09.062_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10157-005-0392-5","article-title":"Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients","volume":"10","author":"Lentine","year":"2006","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.transproceed.2008.09.062_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.transproceed.2005.12.036","article-title":"Chlamydia pneumoniae infection: an additional factor for chronic allograft rejection","volume":"38","author":"Kwiatkowski","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2008.09.062_bib24","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/01.TP.0000120945.54057.16","article-title":"Detection of Chlamydia pneumoniae in liver transplant patients with chronic allograft rejection","volume":"77","author":"Lotz","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.09.062_bib25","first-page":"CR67","article-title":"Impact of Chlamydia pneumoniae infection on survival rate after heart transplantation","volume":"9","author":"Pienia\u0327ek","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.transproceed.2008.09.062_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00003088-199834040-00003","article-title":"Pharmacodynamics and pharmacokinetics of spiramycin and their clinical significance","volume":"34","author":"Brook","year":"1998","journal-title":"Clin Pharmacokinet"},{"issue":"suppl B","key":"10.1016\/j.transproceed.2008.09.062_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/22.Supplement_B.93","article-title":"Pharmacokinetics of spiramycin in man","volume":"22","author":"Frydman","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.transproceed.2008.09.062_bib28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0168-8278(05)80677-4","article-title":"Spiramycin-induced cholestatic hepatitis","volume":"16","author":"Denie","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2008.09.062_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0002-8703(97)70255-2","article-title":"QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates","volume":"133","author":"Stramba-Badiale","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.transproceed.2008.09.062_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jac\/46.2.269","article-title":"Investigation of the anti-inflammatory and membrane-stabilizing potential of spiramycin in vitro","volume":"46","author":"Theron","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1016\/j.transproceed.2008.09.062_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/27.suppl_A.43","article-title":"The in-vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR)","volume":"27","author":"Ridgway","year":"1991","journal-title":"Antimicrob Chemother"},{"key":"10.1016\/j.transproceed.2008.09.062_bib32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/00007890-198905000-00046","article-title":"Absence of interaction between cyclosporine and spiramycin","volume":"47","author":"Birmele","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.09.062_bib33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2125.1989.tb03441.x","article-title":"Lack of effect of spiramycin on cyclosporin pharmacokinetics","volume":"27","author":"Vernillet","year":"1989","journal-title":"Br J Clin Pharmacol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508015728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508015728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:49:23Z","timestamp":1589618963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134508015728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0041134508015728"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2008.09.062","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}